Document Preview Unavailable
Neoadjuvant Intraperitoneal and Systemic Chemotherapy Versus Neoadjuvant Systemic Chemotherapy With Docetaxel, Oxaliplatin, and S-1 for Gastric Cancer With Peritoneal Metastasis: A Propensity Score Matched Analysis
You might have access to this document
-
Try and log in through your institution to see if they have access to the full text.
Log in through your library